This protocol addresses dystonia in patients with adductor-type laryngeal dystonia — a specific laryngeal subtype that warrants a distinct, targeted clinical approach.
The clinical scenario centres on adductor-type laryngeal dystonia. Evidence indicates this subtype can respond to a focused intervention, distinguishing it from other laryngeal conditions such as abductor-type laryngeal dystonia or muscular tension dysphonia.
The structured regimen for this scenario involves a botulinum toxin-based intervention as the primary approach. The complete protocol — including sequencing and clinical decision criteria — is available below.
DOI: 10.1111/j.1468-1331.2010.03042.x
BoNT/A is probably effective for adductor-type laryngeal dystonia, but there is insufficient evidence to support efficacy in abductor-type laryngeal dystonia and in muscular tension dysphonia (good practice point).
View source ↗